Boxer Capital »

Enliven Therapeutics shares owned by Boxer Capital

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Boxer Capital from 13F filings

Historical chart of Boxer Capital investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Boxer Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Boxer Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.9M 646k 13.84
2023-09-30 $8.8M 646k 13.66
2023-06-30 $15M 711k 20.41
2023-03-31 $16M 711k 21.90